Pharmacokinetics and metabolism of14C-labelled alinidine in man an dogs
- 1 July 1981
- journal article
- Published by Springer Nature in European Journal of Drug Metabolism and Pharmacokinetics
- Vol. 6 (3) , 225-236
- https://doi.org/10.1007/bf03189492
Abstract
No abstract availableKeywords
This publication has 13 references indexed in Scilit:
- ALINIDINE REDUCES HEART-RATE WITHOUT BLOCKADE OF BETA-ADRENOCEPTORSThe Lancet, 1981
- Proof of the linearity of the pharmacokinetics of alinidine in manEuropean Journal of Clinical Pharmacology, 1981
- HEMODYNAMIC AND ELECTROPHYSIOLOGIC ACTIONS OF ALINIDINE IN THE DOG1980
- Cardiovascular actions of N-allyl-clonidine (ST 567), a substance with specific bradycardic actionEuropean Journal of Pharmacology, 1979
- N-Allyl-derivative of clonidine, a substance with specific bradycardic action at a cardiac siteNaunyn-Schmiedebergs Archiv für experimentelle Pathologie und Pharmakologie, 1979
- [Metabolic degradation of clonidine (author's transl)].1978
- Clinical pharmacology and pharmacokinetics of clonidineClinical Pharmacology & Therapeutics, 1976
- Identification of 2,6-dichlorophenylguanidine as a metabolite of clonidineJournal of Pharmacy and Pharmacology, 1976
- The pharmacokinetics and metabolism of Kö 592 in man, dog and ratNaunyn-Schmiedebergs Archiv für experimentelle Pathologie und Pharmakologie, 1973
- [Studies on the pharmacokinetics and on the metabolism of 2(2,6-dichlorphenylamino)-2-imidazoline-hydrochloride (St 155)].1969